MEDVi vs TrimRx: Which GLP-1 Provider Is Better?
A side-by-side comparison of MEDVi and TrimRx covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#9 of 318.3/10
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViHigher Rated
TrimRx
#7 of 318.4/10
Budget-friendly compounded GLP-1 provider with straightforward pricing and a focus on accessibility.
Visit TrimRx| Feature | MEDVi | TrimRx |
|---|---|---|
| Our Score | 8.3/10 | 8.4/10 |
| Starting Price | $179/mo | $179/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want affordable compounded GLP-1s with transparent, all-inclusive pricing |
| Ranking | #9 | #7 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
TrimRx
Pros
- +$179/mo all-inclusive for compounded semaglutide — one of the lowest prices for a full-service program
- +Onboarding takes under 15 minutes with same-day provider review for most applications
- +Published patient reviews averaging 4.5+ stars across third-party platforms
- +Free medication replacement if your shipment is lost or damaged in transit
Cons
- −Compounded semaglutide only — no brand-name options and no tirzepatide (compounded or otherwise)
- −No insurance billing, and no superbill provided for out-of-network reimbursement
Our Verdict
TrimRx edges out MEDVi with a score of 8.4/10 vs 8.3/10. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose TrimRx if you want: users who want affordable compounded glp-1s with transparent, all-inclusive pricing.